A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2011
08/23/2011	US8003642 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
08/23/2011	US8003641 Compositions and methods of treating cell proliferation disorders
08/23/2011	US8003640 Organic compounds
08/23/2011	US8003639 Substituted prolinamides, the preparation thereof and the use thereof as pharmaceutical compositions
08/23/2011	US8003638 7-pyrazolylbenzazepines having affinity for D3 receptor
08/23/2011	US8003637 Stabilized atypical antipsychotic formulation
08/23/2011	US8003636 Certain crystalline diphenylazetidinone hydrates, pharmaceutical compositions thereof and methods for their use
08/23/2011	US8003635 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
08/23/2011	US8003634 Analogs of benzoquinone-containing ansamycins and methods of use thereof
08/23/2011	US8003633 Anti-cancer compositions and methods
08/23/2011	US8003632 administerine tacrine, a tacrine analog, fasciculin, metrifonate, heptyl-physostigmine, norpyridostigmine, norneostigmine, huperzine A or an analogue, physostigmine, heptyl-physostigmine etc. free of galantamine to reduce the level of a proinflammatory cytokine
08/23/2011	US8003631 Composition and method for the treatment of tauopathies
08/23/2011	US8003630 Comprises therapeutically effective amounts of at least one chemotherapeutic agent along with the biotherapeutic endogenous pentapeptide Met-enkephalin (opioid growth factor); cancer
08/23/2011	US8003629 21-substituted progesterone derivatives as new antiprogestational agents
08/23/2011	US8003628 Methods of inhibiting osteoclast activity
08/23/2011	US8003627 Urokinase inhibitors
08/23/2011	US8003625 Phosphoramidate alkylator prodrugs
08/23/2011	US8003623 Derived from heparin having a mean molecular weight of 1500-3000 Daltons and an anti-Xa/anti-IIa ratio greater than 30; venous, arterial, or deep vein thromboses; pulmonary embolism; unstable angina; myocardial infarction; and cardiac ischemia
08/23/2011	US8003620 Compositions and their uses directed to diacylglycerol acyltransferase 1
08/23/2011	US8003617 Methods of treating diabetes mellitus
08/23/2011	US8003616 Composition for the treatment of ear infections and method
08/23/2011	US8003615 Stable vitamin B6 derivative
08/23/2011	US8003608 Using small molecule amino acid derivatives
08/23/2011	US8003353 cyanocobalamin at 0.5%, citric acid 0.12%, sodium citrate 0.32%, glycerin 2.23%, benzalkonium chloride 0.02% and 96.79% water; elevating the vitamin B12 levels in the cerebral spinal fluid; intranasally spray
08/23/2011	US8003345 Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure
08/23/2011	US8003141 Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport
08/23/2011	US8003134 Ascorbic acid composition and method for treatment of aging or damaged skin
08/23/2011	US8003132 Compositions comprising an ultraviolet radiation-absorbing polymer
08/23/2011	US8003129 Enhanced transport using membrane disruptive agents
08/23/2011	US8003127 Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereof
08/23/2011	US8003119 Composition for pharmaceutical or dietetic use for combating hair loss
08/23/2011	US8003118 Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
08/23/2011	US8003115 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies
08/23/2011	US8003111 Dimeric alpha interferon pegylated site-specifically shows enhanced and prolonged efficacy in vivo
08/23/2011	US8003101 Inflammatory mediator antagonists
08/23/2011	US8003096 Means and methods for the recruitment and identification of stem cells
08/23/2011	US8003094 Combination with a solvent, skin buffer and antioxidant to improve solubility and bioavailability for a variety of dosage forms
08/23/2011	US8003089 Y shape branched hydrophilic polymer derivatives, their preparation methods, conjugates of the derivatives and drug molecules, and pharmaceutical compositions comprising the conjugates
08/23/2011	US8002830 Biocompatible substrate having plurality of uniform superficial pores and a unique plurality of second uniform superficial pores; hydrogel of polyvinyl alcohol promotes attachment of cartilage; crosslinking; prosthetics; tissue repair and replacement; microelectromechanical systems
08/23/2011	CA2656535C Alkyne-substituted pyridone compounds and methods of use
08/23/2011	CA2634100C Tetomilast polymorphs
08/23/2011	CA2622541C Use of fluorinated triazoles for treating neuropathic pain
08/23/2011	CA2594185C Solid dosage forms comprising a substituted benzimidazole derivative and a buffer
08/23/2011	CA2570763C Composition for preventing onset of cardiovascular events
08/23/2011	CA2532236C Pyridazinyl- piperazines and their use as histamine h3 receptor ligands
08/23/2011	CA2527646C Abuse resistant amphetamine compounds
08/23/2011	CA2520008C Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof
08/23/2011	CA2516333C Drug for reducing side effects in ribavirin / interferon combination therapy
08/23/2011	CA2511464C Non-pegylated long-circulating liposomes
08/23/2011	CA2504820C Pyrazolonaphthyridine derivatives
08/23/2011	CA2501772C Use of dihydroimidazolones for the treatment of epilepsy in dogs
08/23/2011	CA2501659C Deferasirox dispersible tablets
08/23/2011	CA2493330C Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (a) phenanthrenyl ester
08/23/2011	CA2489452C Phenylaminopyrimidines and their use as rho-kinase inhibitors
08/23/2011	CA2486078C Microbicidal pyrimidine or triazine for preventing sexual hiv transmission
08/23/2011	CA2485494C Anti-tumour polycyclic carboxamides
08/23/2011	CA2484070C Antibacterial compositions comprising metal phthalocyanine analogues
08/23/2011	CA2483162C Use of 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino benzo[b]thiophene-2-carboxylic acid derivatives as il-4 inhibitors
08/23/2011	CA2478186C Fluorinated 4-azasteroid derivatives as androgen receptor modulators
08/23/2011	CA2469053C Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
08/23/2011	CA2468845C Stabilized reverse micelle compositions and uses thereof
08/23/2011	CA2463690C Granules containing acid-unstable chemical in large amount
08/23/2011	CA2462276C 3,4-methylenedioxy-substituted chalcones as therapeutic agents
08/23/2011	CA2458632C Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
08/23/2011	CA2456076C Integrin inhibitors for the treatment of eye diseases
08/23/2011	CA2451006C 1,2,4-trioxolane antimalarials
08/23/2011	CA2442159C Treatment using neublastin polypeptides
08/23/2011	CA2415414C Particulate vectors for improving oral absorption of active principles
08/23/2011	CA2410595C Use of aloe-emodin in the treatment of neuroectodermal tumors
08/23/2011	CA2403994C Nasal administration of agents for the treatment of gastroparesis
08/23/2011	CA2396745C Inhibitory or blocking agents of molecular generating and/or inducing functions
08/23/2011	CA2368218C Oat extracts: refining, compositions and methods of use
08/23/2011	CA2348926C Methods and compositions for the prevention of tolerance to medications
08/23/2011	CA2336138C Polymers for delivering nitric oxide in vivo
08/22/2011	CA2693927A1 Use of celivarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization
08/18/2011	WO2011100769A2 Kinase modulators for the treatment of cancer
08/18/2011	WO2011100698A2 Methods of treating viral infection
08/18/2011	WO2011100685A2 Methods of generating hyper inos expressing cells and uses thereof
08/18/2011	WO2011100671A2 Methods and compositions to improve mechanical resistance of teeth
08/18/2011	WO2011100668A1 Methods and compositions of civamide to treat diseases of the intestines
08/18/2011	WO2011100659A2 Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs
08/18/2011	WO2011100642A2 Method for treating hematological cancers
08/18/2011	WO2011100614A1 BENZISOXAZOLES AND AZABENZISOXAZOLES AS mgluR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION
08/18/2011	WO2011100607A1 Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as mglur4 allosteric potentiators, compounds, and methods of treating neurological dysfunction
08/18/2011	WO2011100589A1 Neuroprotection in demyelinating diseases
08/18/2011	WO2011100567A1 Therapeutic inhibition of granulocyte function in demyelinating disease
08/18/2011	WO2011100550A2 Compositions and methods for treating depression
08/18/2011	WO2011100543A2 Methods of reducing or inhibiting toxic effects associated with a bacterial infection using alkaline phosphatase
08/18/2011	WO2011100502A1 7-aminofuropyridine derivatives
08/18/2011	WO2011100455A1 Inhibition of antibody responses to foreign proteins
08/18/2011	WO2011100380A1 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
08/18/2011	WO2011100373A1 Methods and compositions for improving cognitive function
08/18/2011	WO2011100359A1 Cannabinoid agonists
08/18/2011	WO2011100354A1 Removal of virulence factors through extracorporeal therapy
08/18/2011	WO2011100325A2 Polymorphs of sunitinib salts
08/18/2011	WO2011100324A1 Cannabinoid receptor agonists
08/18/2011	WO2011100319A1 Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k and mtor in combination with autophagy inhibitors
08/18/2011	WO2011100308A1 Derivatives of betulin
08/18/2011	WO2011100295A2 Alpha-methyl-tryptophan as an inhibitor of indoleamine dioxygenase
08/18/2011	WO2011100285A1 Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease

1 ... 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 ... 7860